An in vitro FcRn- dependent transcytosis assay as a screening tool for predictive assessment of nonspecific clearance of antibody therapeutics in humans
出版年份 2019 全文链接
标题
An in vitro FcRn- dependent transcytosis assay as a screening tool for predictive assessment of nonspecific clearance of antibody therapeutics in humans
作者
关键词
-
出版物
mAbs
Volume -, Issue -, Pages 1-14
出版商
Informa UK Limited
发表日期
2019-04-15
DOI
10.1080/19420862.2019.1605270
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Development of a label-free FcRn-mediated transcytosis assay for in vitro characterization of FcRn interactions with therapeutic antibodies and Fc-fusion proteins
- (2018) Shan Chung et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A human endothelial cell-based recycling assay for screening of FcRn targeted molecules
- (2018) Algirdas Grevys et al. Nature Communications
- Toward in vitro-to-in vivo translation of monoclonal antibody pharmacokinetics: Application of a neonatal Fc receptor-mediated transcytosis assay to understand the interplaying clearance mechanisms
- (2017) Claudia A. Castro Jaramillo et al. mAbs
- Overcoming disease-specific matrix effect in a clinical pharmacokinetic assay using a microfluidic immunoassay technology
- (2017) Kathi Williams et al. Bioanalysis
- N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins
- (2016) Fabian Higel et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies
- (2016) Lindsay B. Avery et al. mAbs
- Projecting human pharmacokinetics of monoclonal antibodies from nonclinical data: comparative evaluation of prediction approaches in early drug development
- (2015) Jing Wang et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Population pharmacokinetic and exposure–response analysis for trastuzumab administered using a subcutaneous “manual syringe” injection or intravenously in women with HER2-positive early breast cancer
- (2015) Angelica L. Quartino et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics
- (2015) Daniela Bumbaca Yadav et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin
- (2015) Michal Pyzik et al. JOURNAL OF IMMUNOLOGY
- Engineered antibody domains with significantly increased transcytosis and half-life in macaques mediated by FcRn
- (2015) Tianlei Ying et al. mAbs
- Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics
- (2015) Amita Datta-Mannan et al. mAbs
- A novel in vitro assay to predict neonatal Fc receptor-mediated human IgG half-life
- (2015) Colby A Souders et al. mAbs
- Targeting FcRn for the modulation of antibody dynamics
- (2015) E. Sally Ward et al. MOLECULAR IMMUNOLOGY
- Quantitative cumulative biodistribution of antibodies in mice
- (2014) Victor Yip et al. mAbs
- Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge
- (2014) Bing Li et al. mAbs
- In silico selection of therapeutic antibodies for development: Viscosity, clearance, and chemical stability
- (2014) Vikas K. Sharma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Physiological Roles of Asialoglycoprotein Receptors (ASGPRs) Variants and Recent Advances in Hepatic-Targeted Delivery of Therapeutic Molecules Via ASGPRs
- (2014) Jing Hu et al. PROTEIN AND PEPTIDE LETTERS
- Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys
- (2013) Maya K Leabman et al. mAbs
- Analytical FcRn affinity chromatography for functional characterization of monoclonal antibodies
- (2013) Tilman Schlothauer et al. mAbs
- Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity?
- (2013) Brian Gurbaxani et al. MOLECULAR IMMUNOLOGY
- Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity
- (2013) Zenjiro Sampei et al. PLoS One
- Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
- (2012) Narendra Chirmule et al. AAPS Journal
- Effect of antigen binding affinity and effector function on the pharmacokinetics and pharmacodynamics of anti-IgE monoclonal antibodies
- (2012) Deborah L. Mortensen et al. mAbs
- A strategy for risk mitigation of antibodies with fast clearance
- (2012) Isidro Hötzel et al. mAbs
- Production, characterization and pharmacokinetic properties of antibodies with N-linked Mannose-5 glycans
- (2012) Marcella Yu et al. mAbs
- Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting
- (2012) Josef Singer et al. MOLECULAR IMMUNOLOGY
- Engineering neonatal Fc receptor-mediated recycling and transcytosis in recombinant proteins by short terminal peptide extensions
- (2012) J. T. Sockolosky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Monoclonal Antibodies with Identical Fc Sequences Can Bind to FcRn Differentially with Pharmacokinetic Consequences
- (2011) W. Wang et al. DRUG METABOLISM AND DISPOSITION
- Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4
- (2011) Daniela Bumbaca et al. mAbs
- Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data
- (2011) Rong Deng et al. mAbs
- High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice
- (2011) Jin Hee Kim et al. PLoS One
- Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics
- (2010) C. Andrew Boswell et al. BIOCONJUGATE CHEMISTRY
- Pharmacokinetics of Humanized Monoclonal Anti-Tumor Necrosis Factor- Antibody and Its Neonatal Fc Receptor Variants in Mice and Cynomolgus Monkeys
- (2010) R. Deng et al. DRUG METABOLISM AND DISPOSITION
- Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR
- (2010) Takuo Suzuki et al. JOURNAL OF IMMUNOLOGY
- Reduced elimination of IgG antibodies by engineering the variable region
- (2010) T. Igawa et al. PROTEIN ENGINEERING DESIGN & SELECTION
- The recycling and transcytotic pathways for IgG transport by FcRn are distinct and display an inherent polarity
- (2009) Salit Tzaban et al. JOURNAL OF CELL BIOLOGY
- Renal FcRn Reclaims Albumin but Facilitates Elimination of IgG
- (2009) M. Sarav et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Evidence for an Asialoglycoprotein Receptor on Nonparenchymal Cells for O-Linked Glycoproteins
- (2008) E. G. Stefanich et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Neonatal Fc Receptor Mediates Internalization of Fc in Transfected Human Endothelial Cells
- (2008) Nancy A. Goebl et al. MOLECULAR BIOLOGY OF THE CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search